Neuroprotective Agents: all 944 studies that test it
Page 10 of 10. Open to participants first (166), then studies with results posted, then the rest; newest registration first within each.
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's DiseaseCompletedNCT00104442Phase 4
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00104273Phase 2
- Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00099242Phase 3
- Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00099216Phase 3
- SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00093951Phase 2
- Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesStatus unknownNCT00084695Phase 2
- Huperzine A in Alzheimer's DiseaseCompletedNCT00083590Phase 2
- Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe PainCompletedNCT00076544Phase 3
- Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First RelapseStatus unknownNCT00069966Phase 2
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaStatus unknownNCT00053105Phase 1
- Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048776Phase 4
- Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonCompletedNCT00048763Phase 4
- Prialt (Ziconotide) In Severe Chronic PainCompletedNCT00047749Phase 3
- Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownNCT00033072Phase 1
- Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNCT00032929Phase 3
- A Study of Decreased Mental Function Associated With HIVCompletedNCT00027040Not applicable
- Riluzole to Treat Major DepressionCompletedNCT00026052Phase 2
- Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
- Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
- Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV PatientsCompletedNCT00013585Phase 2
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyCompletedNCT00005988Phase 1
- Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary DysplasiaCompletedNCT00004785Phase 3
- Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord InjuryCompletedNCT00004759Phase 3
- Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and SepsisCompletedNCT00004494Phase 1
- Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell MyocarditisCompletedNCT00004482Phase 2
- Absorption of Corticosteroids in Children With Juvenile DermatomyositisCompletedNCT00004357Phase 2
- Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate CancerTerminatedNCT00003682Phase 3
- Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
- T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
- Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3
- Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00002524Phase 2
- A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic PainCompletedNCT00002160Phase 2
- Nefiracetam in the Treatment of Alzheimer's DiseaseCompletedNCT00001933Phase 2
- Treatment of Parkinson's Disease With EliprodilCompletedNCT00001929Phase 2
- The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDSWithdrawnNCT00000741Phase 3
- Infusion Laboratory: Protocol 1 - Selegeline - 2CompletedNCT00000337Phase 1
- Selegiline in Outpatient Treatment for Cocaine Dependence - 1CompletedNCT00000336Phase 2
- Pharmacological Modulation of Cocaine Effects - 1CompletedNCT00000201Phase 2
- Piracetam for Treatment of Cocaine Addiction, Phase II - 4WithdrawnNCT00000199Phase 1
- Piracetam for Treatment of Cocaine Addiction - 3CompletedNCT00000198Phase 1
- Selegiline in Treatment of Cocaine Dependence - 2CompletedNCT00000188Phase 2
- Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)CompletedNCT00000174Phase 3